|
|
U.S. Neurosurgical, Inc. - Earning & Dividend Analysis Snapshot
This detailed Report provides an Earnings and Dividends history for U.S. Neurosurgical, Inc.. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.
U.S. Neurosurgical, Inc.. The Group's principal activity is to own and operate stereotactic radiosurgery centers, utilizing the Gamma Knife technology. The Gamma Knife is a radiosurgical device used to treat brain tumors and other malformations of the brain without invasive surgery. It owns and operates two Gamma Knife centers in Kansas City and New York. It's target market is medical centers in major health care catchment areas that have physicians experienced with and dedicated to use gamma knife. It operates throughout the United States.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|
|
|
|
|